Publications

Publications

Scientific Manuscripts

ACCELERATE scientific manuscripts

2023

2022

2021

  • 2020

    2015-2019

  • Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer
  • Other relevant manuscripts

    Other relevant publications section contain articles from the childhood cancer community which concern ACCELERATE. Various publications can be found here which are relevant to ACCELERATEs mission and/or childhood cancer patient drug development, etc.

    ACCELERATE Platform

    Annual Work Plan

    Executive Summaries

    Annual Conference 2022

    Paediatric Strategy Forums

    Abbreviations

    ALK: anaplastic lymphoma kinase

    BPCA: Biologics Price Competition & Innovation

    CDDF: Cancer Drug Development Forum

    EMA: European Medicines Agency

    ENCCA: European Network for Cancer Research in Children and Adolescents

    FDA: Food and Drug Agency

    IMI: Innovative Medicine Initiative

    ITCC: Innovative Therapies for Children with Cancer

    LTFU: long-term follow-up

    MA: marketing authorisation

    MoA: Mechanism of Action

    PDCO: Paediatric Committee [of the EMA]

    PIP: Paediatric Investigation Plan

    PK: pharmacokinetic

    PPoC: paediatric proof of concept

    PREA: Pediatric Research Equity Act

    PRINTO: Paediatric Rheumatology International Trials Organisation

    SIOPE: European Society for Paediatric Oncology

    US[A]: United States [of America]

    TYA: teenagers and young adults

    WG: Working Group

    WR: written requests

    Share by: